burzynski antineoplaston   opinion burzynski antineoplaston inform current statu research would appreci  burzynski work promis none antineoplaston shown antineoplast effect experiment cancer nci conduct test leukemia mouse result dose high enough produc toxic effect mouse effect inhibit growth tumor kill  burzynski claim activ factor common someth shown extract also shown actual distinct substanc nci conduct seri test use standard panel tumor includ differ cell line tumor follow class leukemia non small cell small cell lung cancer colon cancer cancer central nervou system melanoma ovarian cancer renal cancer exhibit neither growth inhibit cytotox dose level test  necessari process sinc solubl burzynski theori requir solubl agent basic hydrol pag call pag inform carri peptid someth byrzynski claim necessari antineoplast activ also deriv mixtur pa pag pa also peptid purchas chemic suppli hous gram chemic extrem similar glutithamid thalidomid habit form caus peripher neuropathi nasti effect thalidomid wide known spite similar appear test potenti induc teratogen peripher neuropathi  mani burzynski statement origin theori earli research past present support work shown untru   sdb   